characteristics.text: SAMN17083533
characteristics.characteristic: External Id
characteristics.text: Department of Immunology, Medical University of Warsaw
characteristics.characteristic: INSDC center name
characteristics.text: 2022-01-20T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-01-20T01:26:17.503Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS7884102
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS7884102
characteristics.characteristic: SRA accession
characteristics.text: lymphoblasts (CD19+) - patient derived xenograft cells
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: MLL-AF4+ acute lymphoblastic leukemia, patient derived xenograft
characteristics.characteristic: source_name
characteristics.text: spleen
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/BTO_0001281
characteristics.characteristic: tissue
characteristics.text: RNA-seq in MLL-AF4 patient derived xenograft cells - control_2
characteristics.characteristic: title
characteristics.text: vehicle (60percent Phosal 50PG; 30percent PEG400; 10percent Ethanol - by oral gavage) for 3 weeks
characteristics.characteristic: treatment